Skip to content
Screener

Pfizer PFE Q1 2026 earnings

Reported May 5, 2026 · Before market open

Revenue$14.5BBeat by $610.8M
EPS$0.75Beat by $0.04
Revenue estimate$13.8B
EPS estimate$0.71

Next report

Nov 3, 2026 (in a month)
Revenue estimate$15.9B
EPS estimate$0.77

Financials

Q1 2026

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation & ratios

Valuation

as of 03/29/26
See full
Market cap$159.73B+11.1%
Enterprise value$222.4B+9.2%
P/S2.5×+0.2×

Profitability

See full
Gross margin73.5%+1.2pp

Returns & leverage

See full
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Segments

By product

See full
Eliquis$2.2B+12.6%
Prevnar Family$1.7B+1.8%
Vyndaqel family$1.6B+7.8%
Ibrance$1.0B+3.2%
All Other Hospital and Biosimilars$953.0M—

By geography

See full
International Developed Markets$3.4B+7.8%
International Emerging Markets$2.3B+6.0%

By segment

See full
Biopharma$14.2B+5.4%

FAQ

When did Pfizer report Q1 2026 earnings?
Pfizer (PFE) reported Q1 2026 earnings on May 5, 2026 before market open.
What were Pfizer's Q1 2026 revenue and EPS?
Pfizer reported revenue of $14.5B and eps of $0.75 for Q1 2026.
Did Pfizer beat estimates in Q1 2026?
Revenue beat the consensus estimate of $13.8B by $610.8M. EPS beat the consensus estimate of $0.71 by $0.04.
How did Pfizer's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.4% from $13.7B a year earlier and eps declined 18.5% from $0.92.
Where can I find Pfizer's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000078003-26-000053) and the 10-Q periodic report (0000078003-26-000054) directly on SEC EDGAR. The filing index links above go to sec.gov.